HealthCareInternational.Net?
HealthCare International is a social health care related news, articles & blog aggregation system.
Most Popular Published
International Health Care
Top stories in
Health Links
Health Care International - Health Care News & Medical Related Blog Links
Health Care International - Health News, Health Blogs
GTx, Inc. (Nasdaq: GTXI) announced that in a recent Phase III clinical trial of advanced prostate cancer patients being treated with androgen deprivation therapy (ADT), nearly one in four placebo group subjects developed bone fractures or critical b
read more »
GTx, Inc. (Nasdaq: GTXI) announced that in a recent Phase III clinical trial of advanced prostate cancer patients being treated with androgen deprivation therapy (ADT), nearly one in four placebo group subjects developed bone fractures or critical b
read more »
New data presented at the 61st Annual Meeting of the American Academy of Neurology (AAN), in Seattle, U.S.A. show that augmentation did not significantly differ in RLS patients treated with Mirapexin® /Sifrol® (pramipexole*) versus the group receivi
read more »
New data presented at the 61st Annual Meeting of the American Academy of Neurology (AAN), in Seattle, U.S.A. show that augmentation did not significantly differ in RLS patients treated with Mirapexin® /Sifrol® (pramipexole*) versus the group receivi
read more »
New data presented at the 61st Annual Meeting of the American Academy of Neurology (AAN), in Seattle, U.S.A. show that augmentation did not significantly differ in RLS patients treated with Mirapexin® /Sifrol® (pramipexole*) versus the group receivi
read more »
Sepracor Inc. (Nasdaq: SEPR) announced the results of a large-scale, 707-patient Phase III study of OMNARIS® (ciclesonide) HFA, an aerosol nasal formulation of ciclesonide, for the treatment of seasonal allergic rhinitis (SAR) in adult and adolescen
read more »
Sepracor Inc. (Nasdaq: SEPR) announced the results of a large-scale, 707-patient Phase III study of OMNARIS® (ciclesonide) HFA, an aerosol nasal formulation of ciclesonide, for the treatment of seasonal allergic rhinitis (SAR) in adult and adolescen
read more »
Sepracor Inc. (Nasdaq: SEPR) announced the results of a large-scale, 707-patient Phase III study of OMNARIS® (ciclesonide) HFA, an aerosol nasal formulation of ciclesonide, for the treatment of seasonal allergic rhinitis (SAR) in adult and adolescen
read more »
VISOA
Health Resources
Explore Health Care Intl.
Latest Comments
visitors insurance for parents visiting USA from India, China, etc need to...AmericaVisitorInsurance.com also has many visitor insurance plan choices...USvisitorinsurance.net has a good choice of visitor insurance plans for...carries plans from top providers based in the US, ideal visitors coverage...VisitorsHealth.com features many plans for top US based providers that...AtlasAmericaInsurance.net for visitors to USA offers acute onset of...PatriotAmericaInsurance.net is popular for visitors to USA and travelers...VisitorsInsure.com has several plans for visitors to USA...
